Siplizumab: A Deep Analysis into MEDI-507 and 288392-69-8 Siplizumab, previously known as MEDI-507 and bearing the substance designation 288392-69-8, represents a novel antibody designed to precisely target the CD25 molecule, a critical element of the IL-2 network. Its evolution focused on suppressing T-cell proliferation by interferin… Read More